Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
March 21, 2024 10:31 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Asia-Pacific Organ Transplant Diagnostics Market Forecast to Reach $3.45 Billion by 2033 - Advancements in Human Leukocyte Antigen (HLA) Typing Tests Present Opportunities
March 08, 2024 09:37 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.In...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2024 19:01 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
U.S. Organ Procurement Organizations are Strong, CMS Rule Threatens Future Success of Donation System
February 08, 2024 12:18 ET
|
The Association of Organ Procurement Organizations
MCLEAN, Va., Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Association of Organ Procurement Organizations (AOPO) is calling on the Centers for Medicare and Medicaid (CMS) to deliver a plan to stabilize the...
Europe Organ Transplant Diagnostics Market - Comprehensive Analysis and Forecast 2023-2033
January 30, 2024 04:54 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
January 04, 2024 16:40 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023 18:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
November 29, 2023 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
With 6.00% CAGR, Organ Preservation Market Size Worth $348.02 Million by 2030 | Vantage Market Research
November 29, 2023 09:19 ET
|
Vantage Market Research
WASHINGTON, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Global Organ Preservation Market achieved a valuation of $218.36 Million in 2022 and is anticipated to exceed $348.02 Million by 2030, reflecting a...
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
November 09, 2023 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results